Sevelamer, a medication widely given to treat hyperphosphatemia, presents a unique clinical paradox. Its process involves binding to dietary phosphate in the gut , preventing its uptake into the system . Interestingly, this action can sometimes create symptoms that mirror the very condition it's sup